New Nanoparticle Could Protect Bones During Chemotherapy
Researchers have designed a cerium oxide nanoparticle — an artificial enzyme — that protects bones against damage from radiation. The nanoparticle has also shown abilities to improve bone regeneration, reduce loss of blood cells and help kill cancer cells.
AI Tool Finds Link Between Tobacco Smoking and Bladder Cancer
A next-generation machine learning tool has identified patterns of mutations present in bladder cancer that are caused by tobacco smoking.
Immune Targets Identified in Chemotherapy-Resistant Breast Cancers
A deep dive into the gene expression of immune cells in chemotherapy-resistant breast cancers has improved our understanding of the behavior of the immune cells and has highlighted future targets for chemotherapeutics.
Shape-Shifting Fat Cells Fuel Breast Cancer Growth
Study suggests fat cells near malignant breast tumors morph into other cell types, creating "fertile soil" for the disease.
Potential Genetic Marker for Pancreatic Cancer Therapy Identified
Researchers have discovered a genetic marker in pancreatic cancer that may lay the foundations for developing more effective, targeted treatments for pancreatic ductal adenocarcinoma (PDAC).
Researchers Identify Genetic Factors Associated With Drug Resistance in Prostate Cancer
Analysis of the genomic landscape of prostate cancer has enabled researchers to identify the mechanisms by which drug resistance occurs.
Unhealthy Gut Microbiome Can Create Conditions for Breast Cancer To Spread
According to research, disruption of the gut microbiome can lead to the reprogramming of mast cells in breast tissue to facilitate the spread of cancer.
Genomic Testing Can Identify African American Prostate Cancer Patients Who Have High-Risk Disease
Moffitt Cancer Center has conducted the first prospective study to investigate genomic biomarkers associated with aggressive disease in African American men with prostate cancer.
Killer Cells Get Better With Age
Up until now it had been widely assumed that the ability of killer T cells to destroy tumor cells and pathogens would deteriorate with age. It turns out, however, that the opposite is true – they become better killers, the older they get.
Drug Can Differentiate Breast Cancer Cells in Mice To Become Less Harmful
To find new ways to treat aggressive triple-negative breast cancer, researchers have screened thousands of drugs to find one that can differentiate cancer cells, converting them into less harmful cells that no longer divide.